Results presented at the 77th Scientific Sessions of the American Diabetes Association are for combinations with ertugliflozin, an investigational SGLT2 inhibitor before FDA. Ertugliflozin, the ...
The SURPASS program, which consists in part of SURPASS-3 and SURPASS-5, is testing the efficacy and safety of tirzepatide, a novel investigational once-weekly dual glucose-dependent insulinotropic ...
What does an A1C of 7% mean for diabetes management? A target A1C of 7% is a common goal for adults with diabetes, helping reduce long-term complications and improve blood sugar control. For adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results